Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction
2018-000916-75Phase 2Terminated
- Sponsor
- Recardio Inc.
- Start
- Mar 2018
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myocardial infarction (MI) and Acute cardiac ischemia (ACI) comparing Dutogliptin + Filgrastim with Placebo (2 arms). Primary endpoint: Primary Safety Endpoint. Started Mar 2018; status: terminated.
02
Drugs
dutogliptinfilgrastim
03
Conditions
myocardial infarction (MI)Acute cardiac ischemia (ACI)
Beyond the preview
Go deeper on 2018-000916-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000916-75.